Home › Chronic Kidney Disease › Oregon › Portland
Chronic Kidney Disease clinical trials in Portland, OR
4 studies for Chronic Kidney Disease are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease: Patient and Provider Interventions for Patients at High Risk for Chronic Kidney Disease
RecruitingHealthy volunteers welcome
- Center for Health Research, Kaiser Permanente NW, Portland
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
RecruitingPhase 3
- Research Site, Portland
Ferric Citrate and Chronic Kidney Disease in Children
RecruitingPhase 2
- OHSU, Portland
Transformative Research in Diabetic Nephropathy
RecruitingObservational study
- Oregon Health & Science University, Portland
About Chronic Kidney Disease
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
More about Chronic Kidney Disease on MedlinePlus
Chronic Kidney Disease trials in other cities
- New York City, NY17 studies
- Boston, MA15 studies
- Houston, TX15 studies
- Dallas, TX15 studies
- Philadelphia, PA15 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Atlanta, GA10 studies
- Durham, NC9 studies
- Kansas City, MO9 studies
- San Antonio, TX8 studies
- Albuquerque, NM8 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.